Total Liabilities Summary of ResMed Inc.

ResMed Inc.'s latest annual total liabilities in 2024 was 2 Billion USD , down -23.4% from previous year.
ResMed Inc.'s latest quarterly total liabilities in 2024 FY was 2 Billion USD , down -23.4% from previous quarter.
ResMed Inc. reported annual total liabilities of 2.62 Billion USD in 2023, up 51.1% from previous year.
ResMed Inc. reported annual total liabilities of 1.73 Billion USD in 2022, down -5.83% from previous year.
ResMed Inc. reported quarterly total liabilities of 2.42 Billion USD for 2024 Q2, down -2.7% from previous quarter.
ResMed Inc. reported quarterly total liabilities of 2 Billion USD for 2024 Q4, down -8.07% from previous quarter.

Annual Total Liabilities Chart of ResMed Inc. (2024 - 1993)

Historical Annual Total Liabilities of ResMed Inc. (2024 - 1993)

Year	Total Liabilities	Total Liabilities Growth
2024	2 Billion USD	-23.4%
2023	2.62 Billion USD	51.1%
2022	1.73 Billion USD	-5.83%
2021	1.84 Billion USD	-11.86%
2020	2.09 Billion USD	2.7%
2019	2.03 Billion USD	102.55%
2018	1 Billion USD	-33.37%
2017	1.5 Billion USD	-3.57%
2016	1.56 Billion USD	162.01%
2015	596.95 Million USD	-0.96%
2014	602.71 Million USD	0.42%
2013	600.2 Million USD	13.19%
2012	530.24 Million USD	56.79%
2011	338.18 Million USD	-0.2%
2010	338.86 Million USD	-13.73%
2009	392.77 Million USD	21.14%
2008	324.22 Million USD	1.06%
2007	320.82 Million USD	19.23%
2006	269.07 Million USD	-10.33%
2005	300.08 Million USD	64.28%
2004	182.66 Million USD	5.49%
2003	173.16 Million USD	-5.51%
2002	183.26 Million USD	-2.38%
2001	187.72 Million USD	768.21%
2000	21.62 Million USD	18.15%
1999	18.3 Million USD	32.61%
1998	13.8 Million USD	33.98%
1997	10.3 Million USD	30.38%
1996	7.9 Million USD	23.44%
1995	6.4 Million USD	60.0%
1994	4 Million USD	73.91%
1993	2.3 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 FY	2 Billion USD	-23.4%
2024 Q2	2.42 Billion USD	-2.7%
2024 Q4	2 Billion USD	-8.07%
2024 Q1	2.49 Billion USD	-5.01%
2024 Q3	2.18 Billion USD	-9.85%
2023 FY	2.62 Billion USD	51.1%
2023 Q4	2.62 Billion USD	-5.74%
2023 Q2	2.93 Billion USD	68.4%
2023 Q3	2.78 Billion USD	-5.33%
2023 Q1	1.74 Billion USD	0.55%
2022 FY	1.73 Billion USD	-5.83%
2022 Q1	1.7 Billion USD	-7.56%
2022 Q2	1.58 Billion USD	-6.71%
2022 Q3	1.62 Billion USD	2.36%
2022 Q4	1.73 Billion USD	6.68%
2021 Q3	1.87 Billion USD	9.87%
2021 Q2	1.7 Billion USD	-12.06%
2021 Q1	1.94 Billion USD	-7.1%
2021 FY	1.84 Billion USD	-11.86%
2021 Q4	1.84 Billion USD	-1.81%
2020 Q1	2.03 Billion USD	0.09%
2020 FY	2.09 Billion USD	2.7%
2020 Q3	2.25 Billion USD	7.55%
2020 Q4	2.09 Billion USD	-7.27%
2020 Q2	2.09 Billion USD	2.87%
2019 Q4	2.03 Billion USD	-2.01%
2019 Q1	1.16 Billion USD	16.15%
2019 FY	2.03 Billion USD	102.55%
2019 Q3	2.07 Billion USD	9.11%
2019 Q2	1.9 Billion USD	63.09%
2018 Q2	1.54 Billion USD	7.25%
2018 Q3	1.46 Billion USD	-5.0%
2018 Q1	1.44 Billion USD	-4.52%
2018 Q4	1 Billion USD	-31.51%
2018 FY	1 Billion USD	-33.37%
2017 Q1	1.54 Billion USD	-0.92%
2017 Q3	1.56 Billion USD	-2.78%
2017 Q4	1.5 Billion USD	-3.79%
2017 FY	1.5 Billion USD	-3.57%
2017 Q2	1.61 Billion USD	4.05%
2016 Q3	771.19 Million USD	7.9%
2016 Q1	793.86 Million USD	32.99%
2016 Q2	714.74 Million USD	-9.97%
2016 Q4	1.56 Billion USD	102.81%
2016 FY	1.56 Billion USD	162.01%
2015 Q1	656.24 Million USD	8.88%
2015 FY	596.95 Million USD	-0.96%
2015 Q3	741.75 Million USD	0.49%
2015 Q4	596.95 Million USD	-19.52%
2015 Q2	738.11 Million USD	12.48%
2014 Q3	673.66 Million USD	-4.67%
2014 Q2	706.63 Million USD	10.05%
2014 Q1	642.1 Million USD	6.98%
2014 Q4	602.71 Million USD	-10.53%
2014 FY	602.71 Million USD	0.42%
2013 Q3	606.79 Million USD	4.83%
2013 Q4	600.2 Million USD	-1.09%
2013 FY	600.2 Million USD	13.19%
2013 Q2	578.86 Million USD	6.07%
2013 Q1	545.73 Million USD	2.92%
2012 Q3	519.89 Million USD	8.22%
2012 Q2	480.4 Million USD	24.37%
2012 Q1	386.27 Million USD	14.22%
2012 Q4	530.24 Million USD	1.99%
2012 FY	530.24 Million USD	56.79%
2011 FY	338.18 Million USD	-0.2%
2011 Q4	338.18 Million USD	13.19%
2011 Q3	298.76 Million USD	9.28%
2011 Q2	273.4 Million USD	-13.31%
2011 Q1	315.38 Million USD	-6.93%
2010 Q1	417.21 Million USD	6.22%
2010 FY	338.86 Million USD	-13.73%
2010 Q2	363.73 Million USD	-12.82%
2010 Q4	338.86 Million USD	-11.12%
2010 Q3	381.26 Million USD	4.82%
2009 Q3	353.42 Million USD	2.87%
2009 Q1	318.44 Million USD	-1.78%
2009 Q2	343.55 Million USD	7.88%
2009 FY	392.77 Million USD	21.14%
2009 Q4	392.77 Million USD	11.14%
2008 Q2	304.62 Million USD	-0.4%
2008 Q1	305.85 Million USD	-4.66%
2008 Q4	324.22 Million USD	9.36%
2008 Q3	296.48 Million USD	-2.67%
2008 FY	324.22 Million USD	1.06%
2007 Q1	259.54 Million USD	-3.54%
2007 Q3	319.3 Million USD	13.42%
2007 FY	320.82 Million USD	19.23%
2007 Q4	320.82 Million USD	0.48%
2007 Q2	281.52 Million USD	8.47%
2006 Q4	269.07 Million USD	19.7%
2006 FY	269.07 Million USD	-10.33%
2006 Q3	224.78 Million USD	-32.89%
2006 Q2	334.95 Million USD	7.67%
2006 Q1	311.09 Million USD	3.67%
2005 Q4	300.08 Million USD	42.69%
2005 Q1	186.81 Million USD	2.28%
2005 FY	300.08 Million USD	64.28%
2005 Q2	197.09 Million USD	5.5%
2005 Q3	210.29 Million USD	6.7%
2004 FY	182.66 Million USD	5.49%
2004 Q4	182.66 Million USD	-3.41%
2004 Q3	189.11 Million USD	8.81%
2004 Q2	173.8 Million USD	-0.91%
2004 Q1	175.39 Million USD	1.29%
2003 FY	173.16 Million USD	-5.51%
2003 Q4	173.16 Million USD	-1.39%
2003 Q3	175.59 Million USD	4.32%
2003 Q2	168.32 Million USD	-5.25%
2003 Q1	177.64 Million USD	-3.07%
2002 Q3	199.42 Million USD	-10.72%
2002 FY	183.26 Million USD	-2.38%
2002 Q1	224.84 Million USD	19.77%
2002 Q2	223.36 Million USD	-0.66%
2002 Q4	183.26 Million USD	-8.1%
2001 Q3	113.69 Million USD	250.8%
2001 FY	187.72 Million USD	768.21%
2001 Q2	32.4 Million USD	5.23%
2001 Q1	30.79 Million USD	42.44%
2001 Q4	187.72 Million USD	65.12%
2000 Q2	20.2 Million USD	-0.49%
2000 Q4	21.62 Million USD	-9.89%
2000 Q1	20.3 Million USD	10.93%
2000 Q3	23.99 Million USD	18.79%
2000 FY	21.62 Million USD	18.15%
1999 Q2	15.8 Million USD	21.54%
1999 Q1	13 Million USD	-5.8%
1999 Q4	18.3 Million USD	-0.54%
1999 FY	18.3 Million USD	32.61%
1999 Q3	18.4 Million USD	16.46%
1998 Q4	13.8 Million USD	40.82%
1998 FY	13.8 Million USD	33.98%
1998 Q1	9.7 Million USD	-5.83%
1998 Q2	11.6 Million USD	19.59%
1998 Q3	9.8 Million USD	-15.52%
1997 Q1	9.2 Million USD	16.46%
1997 FY	10.3 Million USD	30.38%
1997 Q3	10 Million USD	3.09%
1997 Q2	9.7 Million USD	5.43%
1997 Q4	10.3 Million USD	3.0%
1996 Q3	6.8 Million USD	0.0%
1996 Q4	7.9 Million USD	16.18%
1996 FY	7.9 Million USD	23.44%
1995 FY	6.4 Million USD	60.0%
1995 Q4	6.4 Million USD	0.0%
1994 Q4	4 Million USD	0.0%
1994 FY	4 Million USD	73.91%
1993 FY	2.3 Million USD	0.0%
1993 Q4	2.3 Million USD	0.0%

Peer Total Liabilities Comparison of ResMed Inc.

Name	Total Liabilities	Total Liabilities Difference
Alcon Inc.	8.98 Billion USD	77.653%
AptarGroup, Inc.	2.13 Billion USD	5.737%
Baxter International Inc.	19.8 Billion USD	89.861%
Becton, Dickinson and Company	26.98 Billion USD	92.557%
Bausch + Lomb Corporation	6.52 Billion USD	69.207%
Haemonetics Corporation	1.23 Billion USD	-62.536%
Envista Holdings Corp	2.43 Billion USD	17.393%
Teleflex Incorporated	3.09 Billion USD	35.038%
Warby Parker Inc.	278.52 Million USD	-621.067%
West Pharmaceutical Services, Inc.	948.5 Million USD	-111.74%

Global Stocks Search

ResMed Inc. (RMD)

Total Liabilities Summary of ResMed Inc.

Annual Total Liabilities Chart of ResMed Inc. (2024 - 1993)

Historical Annual Total Liabilities of ResMed Inc. (2024 - 1993)

Peer Total Liabilities Comparison of ResMed Inc.